Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Patient's Package Insert

Patient's Package Insert To the Editor.— I both agree and disagree with Dr McMahon's reactions to the patient package insert issued by the FDA (233:1089, 1975). When I recently wrote "we must recognize that our fundamental Hippocratic responsibility must center upon every patient's best interests,"1 I also meant that a realistic description of possible toxic reactions to a prescribed drug coupled with emphasizing its specific benefits is certainly indicated for some patients. As Dr McMahon pointed out, for other patients such discussion must be limited and sufficiently vague in order to minimize undue anxiety. Of course, one might feel much freer in discussing such potential problems with a patient's close relative. When the toxicity of a drug is being discussed, there is a crucial value in "universalizing the potential toxicity of every drug on the market, including even something as simple as aspirin."2 If we carried the patient package insert to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Patient's Package Insert

Coodley, Alfred
JAMA , Volume 235 (4) – Jan 26, 1976
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/patient-s-package-insert-Kk7CXWGS10

References (1)

Publisher
American Medical Association
Copyright
Copyright © 1976 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1976.03260300010005
Publisher site
See Article on Publisher Site

Abstract

To the Editor.— I both agree and disagree with Dr McMahon's reactions to the patient package insert issued by the FDA (233:1089, 1975). When I recently wrote "we must recognize that our fundamental Hippocratic responsibility must center upon every patient's best interests,"1 I also meant that a realistic description of possible toxic reactions to a prescribed drug coupled with emphasizing its specific benefits is certainly indicated for some patients. As Dr McMahon pointed out, for other patients such discussion must be limited and sufficiently vague in order to minimize undue anxiety. Of course, one might feel much freer in discussing such potential problems with a patient's close relative. When the toxicity of a drug is being discussed, there is a crucial value in "universalizing the potential toxicity of every drug on the market, including even something as simple as aspirin."2 If we carried the patient package insert to

Journal

JAMA – American Medical Association

Published: Jan 26, 1976

There are no references for this article.